Biotech · Public company · Cambridge, MA, US
Obsidian Therapeutics, Inc.
Ticker OBX · SEC CIK 0002130606
Track this companyFree. Adds Obsidian Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- OBX-115Phase 2 · Tumor SkinClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Efficacy of OBX-115 in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Oct 25, 2023ClinicalTrials.gov NCT06060613 · fetched Nov 12, 2026